Growth factors during HCV therapy may be “cost-effective”, but are they “effective”?
Andrew J. Muir, John G. McHutchisonVolume:
44
Année:
2006
Langue:
english
Pages:
4
DOI:
10.1002/hep.21426
Fichier:
PDF, 157 KB
english, 2006